LMCG Investments’s Biogen BIIB Stock Holding History

LMCG Investments’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$2.25M	Sell	7,719 -64	-0.8%	-$21.1K	0.05%	358
2015 Q2	$3.14M	Buy	7,783 +64	+0.8%	+$25.7K	0.07%	333
2015 Q1	$3.26M	Sell	7,719 -55	-0.7%	-$21.7K	0.07%	340
2014 Q4	$2.64M	Sell	7,774 -172	-2%	-$55.6K	0.06%	321
2014 Q3	$2.63M	Sell	7,946 -72	-0.9%	-$23.7K	0.06%	314
2014 Q2	$2.53M	Buy	8,018 +15	+0.2%	+$4.51K	0.05%	331
2014 Q1	$2.45M	Sell	8,003 -933	-10%	-$296K	0.05%	314
2013 Q4	$2.5M	Sell	8,936 -2,948	-25%	-$762K	0.05%	312
2013 Q3	$2.86M	Sell	11,884 -9	-0.1%	-$2.01K	0.07%	293
2013 Q2	$2.56M	Buy	+11,893	New	+$2.54M	0.07%	298

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

LMCG Investments's BIIB Position: Q3 2015 in Review

LMCG Investments reduced its Biogen (BIIB) stake by 0.82% in Q3 2015, selling an estimated $21.1K and leaving 7,719 shares worth $2.25M. The position accounts for 0.05% of the portfolio, ranked #358.

LMCG Investments first reported a position in BIIB in Q2 2013 and has held it in 10 quarters since. The position peaked at $3.26M in Q1 2015. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

LMCG Investments held 7,719 shares of Biogen worth $2.25M as of Q3 2015.
LMCG Investments sold 64 Biogen shares in Q3 2015, an estimated $21.1K.
Biogen made up 0.05% of LMCG Investments's portfolio in Q3 2015, its #358 holding.
LMCG Investments first reported a position in Biogen in Q2 2013 and has held it in 10 quarters since.
LMCG Investments's Biogen position peaked at $3.26M in Q1 2015.
924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on LMCG Investments's 13F filing for Q3 2015, filed 4 Nov 2015.